Nam et al. discovered that valproic acid inhibited the progression of sensorineural hearing loss in a KCNQ4 p.W276S variant model, suggesting it could be a candidate drug to delay hearing loss in some patients [24]. This evidence concerns the gene KCNQ4 and sensorineural hearing loss disorder.